Molecular Medicine and Gene Therapy

Faculty of Medicine | Lund University

Menu

Molecular Medicine and Gene Therapy

bmc view banner

The Division of Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. Established as a joint venture between the Medical Faculty at Lund University and the Hematology Clinic at Lund University Hospital, our mission is to translate basic science to clinical applications.

Our research focuses on hematopoiesis, the continuous and dynamic process of blood cell formation. The laboratory consists of eight closely collaborating research groups that all share a common interest in investigating the properties of blood stem cells to eventually understand and treat hematological disorders.

Five of our researchers belong to the Hemato-Linné Excellence Linnaeus Research Environment funded by The Swedish Research Council and Lund University. Several of the groups are engaged in StemTherapy, a Strategic Research Area for Stem Cells and Regenerative Medicine that is also supported by The Swedish Research Council.

News

Congratulations to Charlotta Böiers and Valgardur Sigurdsson on being awarded a four-year research assistant position each from the Swedish Childhood Cancer Foundation. Out of 22 applications, Charlotta and Valgardur were two of five researchers who were awarded funding.

In addition, Agatheeswaran Subramaniam, postdoctoral fellow in the Larsson lab, has been awarded a postdoctoral fellowship from the Swedish Cancer Society. Congratulations to all of you!

valgardur sigurdsson

Valgardur Sigurdsson 

Awarded 4-year research assistant position from the Swedish Childhood Cancer Foundation

Project title: Inflammation control and chemotherapy in paediatric cancer

charlotta boeiers

Charlotta Böiers

Awarded 4-year research assistant position from the Swedish Childhood Cancer Foundation

Project title: Unraveling the origin of MLL-AF4 associated infant Acute Lymphoblastic Leukemia 

agatheeswaran subramaniam

Agatheeswaran Subramaniam

Awarded 3-year postdoctoral fellow position from the Swedish Cancer Society

Project title: Inducing synthetic lethality as a novel therapeutic strategy in STAG2 mutated AML leukemic stem cells 

dissertation karolina komorowska
On March 14, Karolina Komorowska successfully defended her thesis entitled "The Role of Hepatic Leukemia Factor in Hematopoiesis".

Faculty opponent was Professor David Traver, University of California, San Diego School of Medicine, USA. Main supervisor for Karolina's PhD studies was Assistant Professor Mattias Magnusson.

From left: Ewa Sitnicka Quinn, David Traver, Karolina Komorowska, Johan Flygare, Mattias Magnusson, Jonas Larsson, Hong Qian, Håkan Axelson.
Photo credit: Claire McKay

The Pereira lab is expanding. Please welcome our new colleagues Cristiana Pires, Olga Zimmermannova, and Fábio Rosa to Filipe Pereira's group. Cristiana and Olga recently started their postdoctoral trainings, while Fábio joined the group as a PhD student. Welcome to the Division of Molecular Medicine and Gene Therapy and to Lund Stem Cell Center, Cristiana, Olga, and Fábio!

Please welcome our new colleagues Yang Liu and Elin Arvidsson to the Division of Molecular Medicine and Gene Therapy. Yang recently started her postdoctoral training in Stefan Karlsson's group, while Elin joined the Larsson lab as a Bachelor student.

Welcome to our Division, Yang and Elin.

k komorowska
Karolina Komorowska

On March 14, Karolina Komorowska will defend her thesis entitled “The Role of Hepatic Leukemia Factor in Hematopoiesis ".

Time and venue

Wednesday 14 March at 9.30 am; LUX room C126

Opponent

Professor David Traver, University of California, San Diego School of Medicine

Main supervisor

Principal Investigator Mattias Magnusson

Chair

Docent Johan Flygare

Welcome!

Site overview